2022 - Research.com Best Scientist Award
2018 - Fellow of the American Association for the Advancement of Science (AAAS)
2018 - Louisa Gross Horwitz Prize, Columbia University
2016 - Fellow, National Academy of Inventors
2007 - Albany Medical Center Prize in Medicine and Biomedical Research
2006 - Canada Gairdner International Award
2004 - Albert Lasker Award for Basic Medical Research, Lasker Foundation
2003 - Member of the National Academy of Medicine (NAM)
2003 - Keio Medical Science Prize, Keio University, Tokyo, Japan
2003 - Alfred P. Sloan Jr. Prize, General Motors Cancer Research Foundation
1997 - Fellow of the American Academy of Arts and Sciences
1992 - Robert J. and Claire Pasarow Foundation Medical Research Award
1989 - Member of the National Academy of Sciences
Nuclear receptor, Receptor, Cell biology, Endocrinology and Internal medicine are his primary areas of study. His Nuclear receptor study incorporates themes from Molecular biology and Signal transduction. Ronald M. Evans focuses mostly in the field of Receptor, narrowing it down to matters related to Transcription and, in some cases, Glucocorticoid receptor, Transcription factor and Glucocorticoid.
His Cell biology research incorporates themes from Genetics, Cellular differentiation, CD36, DNA-binding protein and Corepressor. His Endocrinology research includes elements of Peroxisome proliferator-activated receptor, GW501516, Cancer research and Peroxisome proliferator-activated receptor delta. Many of his research projects under Internal medicine are closely connected to Placenta with Placenta, tying the diverse disciplines of science together.
His primary areas of investigation include Cell biology, Nuclear receptor, Receptor, Internal medicine and Endocrinology. His Cell biology research is multidisciplinary, incorporating perspectives in Cell, Genetics, Gene expression, Molecular biology and Transcription. His studies deal with areas such as Thyroid hormone receptor, Cancer research and Signal transduction as well as Nuclear receptor.
His Receptor study introduces a deeper knowledge of Biochemistry. His Endocrinology study combines topics in areas such as Peroxisome proliferator-activated receptor and Peroxisome proliferator-activated receptor delta. The concepts of his Retinoid X receptor study are interwoven with issues in Retinoid X receptor gamma and Retinoid X receptor alpha.
His main research concerns Internal medicine, Cell biology, Endocrinology, Cancer research and Nuclear receptor. His Internal medicine research integrates issues from Type 2 diabetes and Oncology. His work in Cell biology covers topics such as Circadian clock which are related to areas like Transcription.
The study of Endocrinology is intertwined with the study of Receptor in a number of ways. His Cancer research research includes themes of Tumor microenvironment, Epigenetics, Calcitriol receptor and Pancreatic cancer. His work carried out in the field of Nuclear receptor brings together such families of science as Peroxisome proliferator-activated receptor and Retinoic acid.
Ronald M. Evans focuses on Cell biology, Internal medicine, Endocrinology, Cancer research and Nuclear receptor. Ronald M. Evans has included themes like Genetics, Cell and Circadian clock in his Cell biology study. His Internal medicine research is multidisciplinary, relying on both Farnesoid X receptor and Oncology.
His study in Endocrinology is interdisciplinary in nature, drawing from both Fexaramine and FGF19, FGF15. The study incorporates disciplines such as Chromatin, Receptor and Regulation of gene expression in addition to Nuclear receptor. His work in Receptor addresses subjects such as Retinoid X receptor, which are connected to disciplines such as Rhodopsin-like receptors, Class C GPCR, PELP-1, Retinoid X receptor alpha and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The steroid and thyroid hormone receptor superfamily
Ronald M. Evans.
The nuclear receptor superfamily: the second decade.
David J. Mangelsdorf;Carl Thummel;Miguel Beato;Peter Herrlich.
The RXR heterodimers and orphan receptors
David J. Mangelsdorf;Ronald M. Evans.
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Barry M. Forman;Barry M. Forman;Peter Tontonoz;Jasmine Chen;Regina P. Brun.
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
Michael G. Rosenfeld;Jean-Jacques Mermod;Susan G. Amara;Larry W. Swanson.
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
Barry Marc Forman;Jasmine Chen;Ronald M. Evans.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
Susan G. Amara;Vivian Jonas;Michael G. Rosenfeld;Estelita S. Ong.
Transcriptional co-repressor that interacts with nuclear hormone receptors
Ronald M. Evans;J. Don Chen.
Nuclear receptors and lipid physiology: opening the X-files.
Ajay Chawla;Joyce J. Repa;Ronald M. Evans;David J. Mangelsdorf.
Identification of a receptor for the morphogen retinoic acid.
Vincent Giguere;Estelita S. Ong;Prudimar Segui;Ronald M. Evans.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: